About this Journal Submit a Manuscript Table of Contents
Sarcoma
Volume 2013 (2013), Article ID 520858, 8 pages
http://dx.doi.org/10.1155/2013/520858
Research Article

MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma

1Pediatric Cancer Biology Program, Department of Pediatrics, Papé Family Pediatric Research Institute, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Mail Code L321, Portland, OR 97239-3098, USA
2Department of Pathology, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Mail Code L41, Portland, OR 97239-3098, USA
3Division of Hematology-Oncology, Department of Medicine, Oregon Health & Science University, Portland, OR 97239, USA
4Department of Radiation Oncology, Oregon Health & Science University, Portland, OR 97239, USA
5Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA

Received 9 March 2013; Accepted 24 April 2013

Academic Editor: Cyril Fisher

Copyright © 2013 Ken Kikuchi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Ken Kikuchi, George R. Wettach, Christopher W. Ryan, et al., “MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma,” Sarcoma, vol. 2013, Article ID 520858, 8 pages, 2013. doi:10.1155/2013/520858